KIMBERLY HUNSUCKER: Open Payments
NPI 1134656606 · MYRTLE BEACH, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,548 in 77 payments from 19 companies in 2025. Trend: 2023 $824 · 2024 $1,034 · 2025 $1,548
Food & beverage: $1,548
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 13 | $348 |
| Amgen Inc. | 12 | $278 |
| Lilly USA, LLC | 5 | $169 |
| GlaxoSmithKline, LLC. | 8 | $136 |
| AstraZeneca Pharmaceuticals LP | 5 | $77 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $76 |
| PFIZER INC. | 4 | $64 |
| Abbott Laboratories | 3 | $56 |
| Daiichi Sankyo Inc. | 2 | $53 |
| Phathom Pharmaceuticals, Inc. | 7 | $47 |
Products named: Ozempic, MOUNJARO, Repatha, Wegovy, TRELEGY ELLIPTA, OTEZLA, XIFAXAN, FREESTYLE LIBRE 3.
Industry payments across SC — which companies pay providers there.
